Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8A1E

Rabies virus glycoprotein in complex with Fab fragments of 17C7 and 1112-1 neutralizing antibodies

8A1E の概要
エントリーDOI10.2210/pdb8a1e/pdb
EMDBエントリー15073
分子名称Glycoprotein, Fab 17C7 heavy chain variable domain, Fab 17C7 light chain variable domain, ... (5 entities in total)
機能のキーワードviral glycoprotein, antibody, complex, viral protein
由来する生物種Rabies virus strain Pasteur vaccin
詳細
タンパク質・核酸の鎖数5
化学式量合計106571.37
構造登録者
Ng, W.M.,Fedosyuk, S.,English, S.,Augusto, G.,Berg, A.,Thorley, L.,Haselon, A.S.,Segireddy, R.R.,Bowden, T.A.,Douglas, A.D. (登録日: 2022-06-01, 公開日: 2022-08-17, 最終更新日: 2024-11-06)
主引用文献Ng, W.M.,Fedosyuk, S.,English, S.,Augusto, G.,Berg, A.,Thorley, L.,Haselon, A.S.,Segireddy, R.R.,Bowden, T.A.,Douglas, A.D.
Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies.
Cell Host Microbe, 30:1219-1230.e7, 2022
Cited by
PubMed Abstract: Rabies virus (RABV) causes lethal encephalitis and is responsible for approximately 60,000 deaths per year. As the sole virion-surface protein, the rabies virus glycoprotein (RABV-G) mediates host-cell entry. RABV-G's pre-fusion trimeric conformation displays epitopes bound by protective neutralizing antibodies that can be induced by vaccination or passively administered for post-exposure prophylaxis. We report a 2.8-Å structure of a RABV-G trimer in the pre-fusion conformation, in complex with two neutralizing and protective monoclonal antibodies, 17C7 and 1112-1, that recognize distinct epitopes. One of these antibodies is a licensed prophylactic (17C7, Rabishield), which we show locks the protein in pre-fusion conformation. Targeted mutations can similarly stabilize RABV-G in the pre-fusion conformation, a key step toward structure-guided vaccine design. These data reveal the higher-order architecture of a key therapeutic target and the structural basis of neutralization by antibodies binding two key antigenic sites, and this will facilitate the development of improved vaccines and prophylactic antibodies.
PubMed: 35985336
DOI: 10.1016/j.chom.2022.07.014
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.83 Å)
構造検証レポート
Validation report summary of 8a1e
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon